Cite
MLA Citation
L. Horn et al.. “3010 Phase, randomized trial (CheckMate 057) of nivolumab (NIVO) vs docetaxel (DOC) in advanced non-squamous (non-SQ) non-small cell lung cancer (NSCLC): Subgroup analyses and patient reported outcomes (PROs).” European journal of cancer, vol. 51, n.d., pp. S599–. http://access.bl.uk/ark:/81055/vdc_100030628298.0x00005b